Ticiana Leal, MD, a distinguished oncologist from the Winship Cancer Institute of Emory University, shared her insights during a discussion on the use of Electric Field (ED) therapy for lung cancer, addressing the ongoing challenges and areas for future research.
In response to a question posed by Allen Wilbanks, Dr. Leal remarked, “Yeah, I think we’re going to continue to investigate the use of TT fields in non-small cell lung cancer.”
With a poised demeanor, Dr. Leal highlighted the importance of comprehending how to integrate TT (Tumor Treating) fields into the existing landscape of systemic therapies. She emphasized this need, not only for patients who are immunotherapy naive in the frontline setting but also for those with locally advanced disease following concurrent chemo-radiation.
Watch the full interview with Ticiana Leal, MD here